Literature DB >> 10602378

C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells.

A Sponaas1, C Carstens, N Koch.   

Abstract

In vitro and in vivo activation of T cells was investigated with invariant chain-antigen fusion protein. The CD4 T cell epitope amino acid 52-61 of hen egg lysozyme (HEL) was attached to the C-terminal end of invariant chain (Ii). Expression of this recombinant Ii HEL directs the T cell epitope to the class II processing pathway. Class II molecules of transfected antigen presenting cells (APC) are charged with this HEL epitope. The endogenously provided epitope competes with processing and presentation of exogenously added antigen. APC expressing recombinant Ii HEL stimulate a maximal IL-2 response of HEL-specific T hybridoma cells. Nonprofessional APC expressing recombinant Ii HEL and H2-Ak are also able to activate naive T cells from 3A9 TCR transgenic mice, a result not achieved with peptide pulsed APC. To elicit an in vivo immune response dendritic cells (DC) were transfected with rIi HEL cDNA: following immunization of CBA mice with transfected DC, a primary T cell response against the HEL epitope was induced. Thus the procedure described here could be used to introduce antigens into the class II processing pathway and to elicit T cell activation both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602378     DOI: 10.1038/sj.gt.3301021

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  5 in total

Review 1.  Specific immunotherapy of cancer in elderly patients.

Authors:  S Matzku; M Zöller
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Fusion to the Lysosome Targeting Signal of the Invariant Chain Alters the Processing and Enhances the Immunogenicity of HIV-1 Reverse Transcriptase.

Authors:  E S Starodubova; M G Isaguliants; Y V Kuzmenko; A A Latanova; O A Krotova; V L Karpov
Journal:  Acta Naturae       Date:  2014-01       Impact factor: 1.845

3.  Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Authors:  Alexandra J Spencer; Matthew G Cottingham; Jennifer A Jenks; Rhea J Longley; Stefania Capone; Stefano Colloca; Antonella Folgori; Riccardo Cortese; Alfredo Nicosia; Migena Bregu; Adrian V S Hill
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

4.  Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses.

Authors:  Benedict R Halbroth; Sarah Sebastian; Hazel C Poyntz; Migena Bregu; Matthew G Cottingham; Adrian V S Hill; Alexandra J Spencer
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

Review 5.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.